Tunes Pharma
Contact Us
RESGABA-DLX
✅
DCGI Approved
Certified & Compliant
🏭
WHO-GMP
Certified Manufacturing
Home› Products› RESGABA-DLX
Ortho

RESGABA-DLX

RESGABA-DLX combines Pregabalin and Duloxetine for dual-action management of chronic neuropathic pain. Pregabalin modulates calcium channels in hyperexcited neurons while Duloxetine (SNRI) inhibits serotonin and noradrenaline reuptake to enhance descending pain control.

Sch. H
Schedule
10×10 Capsules (Alu-Alu)
Packing
Tunes...
Manufacturer
GMP
Certified
Order Now Request Sample
← Back to all products
Description
RESGABA-DLX combines Pregabalin and Duloxetine for dual-action management of chronic neuropathic pain. Pregabalin modulates calcium channels in hyperexcited neurons while Duloxetine (SNRI) inhibits serotonin and noradrenaline reuptake to enhance descending pain control.
Indication
Chronic neuropathic pain, diabetic peripheral neuropathy, generalized anxiety disorder, fibromyalgia
Key Benefits
Superior pain relief through central and peripheral sensitization blockade, mood improvement, and reduced anxiety — especially beneficial in patients with comorbid depression and chronic pain.
Dosage / How to Use
Take once or twice daily as directed. Do not crush, chew or open capsules. Do not stop abruptly — taper gradually.
Features
Pregabalin 75mg + Duloxetine 30mg
Storage
Store below 30°C in a dry place away from moisture and direct sunlight.
Active Ingredients

Composition Breakdown

Each ingredient is carefully selected and clinically validated for synergistic therapeutic outcomes.

Full Composition
Pregabalin 75mg + Duloxetine 30mg
1
🧪
Pregabalin 75mg
Modulates calcium channels to reduce neuropathic pain signalling.
2
💊
Duloxetine 30mg
SNRI that targets central sensitization and mood stabilisation.
Clinical Indication
Chronic neuropathic pain, diabetic peripheral neuropathy, generalized anxiety disorder, fibromyalgia
Dosage & Administration
Take once or twice daily as directed. Do not crush, chew or open capsules. Do not stop abruptly — taper gradually.
Side Effects
Nausea, dizziness, dry mouth, constipation, somnolence, hyperhidrosis. Monitor for suicidal ideation in initial weeks.
Quality & Regulatory

Compliance Standards

Every product meets stringent national and international pharmaceutical quality standards.

✅
DCGI Approved
Approved by Drug Controller General of India under Schedule H regulations.
🏭
WHO-GMP Certified
Manufacturing partners hold WHO-GMP certification ensuring global quality standards.
🔬
Clinically Tested
Formulations backed by clinical evidence for safety and therapeutic efficacy.
🛡️
Quality Assured
Rigorous QC testing at every stage from raw material to finished product.
Manufactured By
Tunes Therapeutics Pvt. Ltd.
Drug Schedule
Schedule H — Prescription only medication. To be sold by retail on the prescription of a Registered Medical Practitioner only.

Ready to prescribe RESGABA-DLX?

Contact our field team for samples, pricing, and territory availability.

Order Now Contact Team